MedTrace Logo

Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients

NCT01343680 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2012-05-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether flushing Central Venous Catheters (CVCs) with Normal saline once per week is not inferior to flushing with 10U/ml heparin 3 times per week, in preventing CVC occlusions.

Conditions

Interventions

DRUG

Heparin

5ml 10 units/ml IV heparin 3 times per week

DRUG

Normal saline

10ml normal saline IV weekly

Sponsors & Collaborators

  • Stollery Children's Hospital

    collaborator OTHER

  • Alberta Children's Hospital

    lead OTHER

Principal Investigators

  • Martin A Campbell, MBBS FRACP · Alberta Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01343680 on ClinicalTrials.gov